Validity and Reliability of an Activity Monitor in Persons With a Cerebrovascular Accident
Launched by UNIVERSITY COLLEGE OF ANTWERP · Feb 20, 2009
Trial Information
Current as of July 22, 2025
Completed
Keywords
ClinConnect Summary
Evaluation of the SenseWear Pro Armband to assess physical activity in individuals with chronic stroke
Background:
Accelerometry has only recently been introduced in clinical stroke research. However, whether accelerometry is a valid and reliable tool in stroke needs to be established. From literature becomes clear that existing accelerometers show shortages at patients with stroke because of the specific deficits that these patients have.
Purpose:
The aim of this study is to investigate the validity and test-retest reliability of the SenseWear Pro armband as an objective measurement of...
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • an ischemic or hemorrhagic stroke
- • stroke onset less than 3 months
- • score 3 or more Functional Ambulation Categories
- • age \< 80 years
- • ability to cycle independently
- • written authorisation on the informed consent
- Exclusion criteria:
- • serious other diseases which might have an influence on carrying out the standardised activities
- • cannot understand and carry out simple instructions
About University College Of Antwerp
The University College of Antwerp is a distinguished academic institution dedicated to advancing education and research in the health sciences. As a clinical trial sponsor, it leverages its robust expertise and innovative methodologies to conduct cutting-edge research aimed at improving patient outcomes and healthcare practices. The institution fosters collaboration among multidisciplinary teams to ensure the highest ethical standards and scientific rigor in clinical trials. Committed to translating research findings into practical applications, the University College of Antwerp plays a pivotal role in contributing to the advancement of medical knowledge and the development of new therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edegem, Antwerp, Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials